| Literature DB >> 29377010 |
Steven E Arnold1, Zoe Arvanitakis2, Shannon L Macauley-Rambach3, Aaron M Koenig1, Hoau-Yan Wang4, Rexford S Ahima5, Suzanne Craft6, Sam Gandy7, Christoph Buettner8, Luke E Stoeckel9, David M Holtzman3, David M Nathan9.
Abstract
Considerable overlap has been identified in the risk factors, comorbidities and putative pathophysiological mechanisms of Alzheimer disease and related dementias (ADRDs) and type 2 diabetes mellitus (T2DM), two of the most pressing epidemics of our time. Much is known about the biology of each condition, but whether T2DM and ADRDs are parallel phenomena arising from coincidental roots in ageing or synergistic diseases linked by vicious pathophysiological cycles remains unclear. Insulin resistance is a core feature of T2DM and is emerging as a potentially important feature of ADRDs. Here, we review key observations and experimental data on insulin signalling in the brain, highlighting its actions in neurons and glia. In addition, we define the concept of 'brain insulin resistance' and review the growing, although still inconsistent, literature concerning cognitive impairment and neuropathological abnormalities in T2DM, obesity and insulin resistance. Lastly, we review evidence of intrinsic brain insulin resistance in ADRDs. By expanding our understanding of the overlapping mechanisms of these conditions, we hope to accelerate the rational development of preventive, disease-modifying and symptomatic treatments for cognitive dysfunction in T2DM and ADRDs alike.Entities:
Mesh：
Substances：
Year: 2018 PMID： 29377010 PMCID： PMC6098968 DOI： 10.1038/nrneurol.2017.185
Source DB: PubMed Journal: Nat Rev Neurol ISSN： 1759-4758 Impact factor: 42.937